View in EDS

Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.

Saved in:
Bibliographic Details
Title: Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
Authors: Smith CR; Mirati Therapeutics, San Diego, California 92121, United States., Aranda R; Mirati Therapeutics, San Diego, California 92121, United States., Bobinski TP; DSG, San Diego, California 92130, United States., Briere DM; Mirati Therapeutics, San Diego, California 92121, United States., Burns AC; Mirati Therapeutics, San Diego, California 92121, United States., Christensen JG; Mirati Therapeutics, San Diego, California 92121, United States., Clarine J; Mirati Therapeutics, San Diego, California 92121, United States., Engstrom LD; Mirati Therapeutics, San Diego, California 92121, United States., Gunn RJ; Mirati Therapeutics, San Diego, California 92121, United States., Ivetac A; Mirati Therapeutics, San Diego, California 92121, United States., Jean-Baptiste R; ZoBio BV, J. H. Oortweg 19, 2333 CH Leiden, Netherlands., Ketcham JM; Mirati Therapeutics, San Diego, California 92121, United States., Kobayashi M; ZoBio BV, J. H. Oortweg 19, 2333 CH Leiden, Netherlands., Kuehler J; Mirati Therapeutics, San Diego, California 92121, United States., Kulyk S; Mirati Therapeutics, San Diego, California 92121, United States., Lawson JD; Mirati Therapeutics, San Diego, California 92121, United States., Moya K; Mirati Therapeutics, San Diego, California 92121, United States., Olson P; Mirati Therapeutics, San Diego, California 92121, United States., Rahbaek L; Mirati Therapeutics, San Diego, California 92121, United States., Thomas NC; Mirati Therapeutics, San Diego, California 92121, United States., Wang X; Mirati Therapeutics, San Diego, California 92121, United States., Waters LM; Mirati Therapeutics, San Diego, California 92121, United States., Marx MA; Mirati Therapeutics, San Diego, California 92121, United States.
Source: Journal of medicinal chemistry [J Med Chem] 2022 Feb 10; Vol. 65 (3), pp. 1749-1766. Date of Electronic Publication: 2022 Jan 18.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35041419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smith+CR%22">Smith CR</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Aranda+R%22">Aranda R</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Bobinski+TP%22">Bobinski TP</searchLink>; DSG, San Diego, California 92130, United States.<br /><searchLink fieldCode="AU" term="%22Briere+DM%22">Briere DM</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Burns+AC%22">Burns AC</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Christensen+JG%22">Christensen JG</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Clarine+J%22">Clarine J</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Engstrom+LD%22">Engstrom LD</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Gunn+RJ%22">Gunn RJ</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Ivetac+A%22">Ivetac A</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Jean-Baptiste+R%22">Jean-Baptiste R</searchLink>; ZoBio BV, J. H. Oortweg 19, 2333 CH Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Ketcham+JM%22">Ketcham JM</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Kobayashi+M%22">Kobayashi M</searchLink>; ZoBio BV, J. H. Oortweg 19, 2333 CH Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuehler+J%22">Kuehler J</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Kulyk+S%22">Kulyk S</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Lawson+JD%22">Lawson JD</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Moya+K%22">Moya K</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Olson+P%22">Olson P</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Rahbaek+L%22">Rahbaek L</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Thomas+NC%22">Thomas NC</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Waters+LM%22">Waters LM</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Marx+MA%22">Marx MA</searchLink>; Mirati Therapeutics, San Diego, California 92121, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2022 Feb 10; Vol. 65 (3), pp. 1749-1766. <i>Date of Electronic Publication: </i>2022 Jan 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35041419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.jmedchem.1c01900
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1749
    Titles:
      – TitleFull: Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smith CR
      – PersonEntity:
          Name:
            NameFull: Aranda R
      – PersonEntity:
          Name:
            NameFull: Bobinski TP
      – PersonEntity:
          Name:
            NameFull: Briere DM
      – PersonEntity:
          Name:
            NameFull: Burns AC
      – PersonEntity:
          Name:
            NameFull: Christensen JG
      – PersonEntity:
          Name:
            NameFull: Clarine J
      – PersonEntity:
          Name:
            NameFull: Engstrom LD
      – PersonEntity:
          Name:
            NameFull: Gunn RJ
      – PersonEntity:
          Name:
            NameFull: Ivetac A
      – PersonEntity:
          Name:
            NameFull: Jean-Baptiste R
      – PersonEntity:
          Name:
            NameFull: Ketcham JM
      – PersonEntity:
          Name:
            NameFull: Kobayashi M
      – PersonEntity:
          Name:
            NameFull: Kuehler J
      – PersonEntity:
          Name:
            NameFull: Kulyk S
      – PersonEntity:
          Name:
            NameFull: Lawson JD
      – PersonEntity:
          Name:
            NameFull: Moya K
      – PersonEntity:
          Name:
            NameFull: Olson P
      – PersonEntity:
          Name:
            NameFull: Rahbaek L
      – PersonEntity:
          Name:
            NameFull: Thomas NC
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Waters LM
      – PersonEntity:
          Name:
            NameFull: Marx MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2022 Feb 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1520-4804
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of medicinal chemistry
              Type: main
ResultId 1